Related Experiment Video
Updated: Apr 1, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
Polymeric nanostructures with pH-labile core for controlled drug release.
Rakesh Banerjee1, Saikat Maiti1, Debabrata Dey1
1Department of Chemistry, Indian Institute of Technology Kharagpur, West Bengal 721302, India.
Researchers developed novel core cross-linked polymeric nanostructures (CLPN) for drug delivery. These nanoparticles show pH- and temperature-triggered drug release, offering a promising platform for advanced therapeutics.
Area of Science:
- Materials Science
- Polymer Chemistry
- Nanotechnology
Background:
- Stimuli-triggered controlled drug delivery is crucial for advanced therapeutics.
- Developing versatile and efficient nanocarriers remains a significant challenge.
Purpose of the Study:
- To synthesize core cross-linked polymeric nanostructures (CLPN) using a Michael addition reaction.
- To evaluate the drug encapsulation and release capabilities of the CLPN.
- To investigate the pH- and temperature-responsive release behavior of the nanocarriers.
Main Methods:
- Synthesis of acrylate-functionalized triblock copolymer (poly(ethylene glycol)-b-poly(N-isopropylacrylamide)-b-poly(acrylic acid)).
- Formation of CLPN via Michael addition between acrylate groups and thiol-functionalized cross-linker.
- Drug encapsulation studies and in vitro release assays under varying pH and temperature conditions.
Main Results:
- Successfully synthesized CLPN with controllable size and structure.
- Demonstrated efficient encapsulation of model drug molecules within the nanoparticle core.
- Observed pH-triggered degradation of the core leading to drug release.
- Confirmed temperature-sensitive drug release behavior.
- Established the non-toxic nature of both precursor polymers and CLPN.
Conclusions:
- The developed CLPN offer a versatile platform for stimuli-responsive drug delivery.
- The pH- and temperature-triggered release mechanisms highlight their potential for targeted and controlled therapeutic applications.
- The non-toxic profile supports their suitability as drug carriers in advanced therapy.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Classification
Oral Drug Delivery Systems: Delayed-Release Systems
Modified-Release Drug Delivery Systems: Rate-Programmed I

